Bessemer Group
TECX

Bessemer Group’s Tectonic Therapeutic TECX Stock Holding History

Bessemer Group’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,048
Closed -$253K – 1740
2019
Q4 		$253K Hold
1,048
– – ﹤0.01% 1036
2019
Q3 		$178K Sell
1,048
-675
-39% -$153K ﹤0.01% 1082
2019
Q2 		$336K Buy
+1,723
New +$372K ﹤0.01% 958

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Bessemer Group's TECX Position: Q1 2020 in Review

Bessemer Group sold out of Tectonic Therapeutic (TECX) in Q1 2020, closing a stake of 1,048 shares — an estimated $253K sold.

Bessemer Group first reported a position in TECX in Q2 2019 and held it in 3 quarters. The position peaked at $336K in Q2 2019. 92 funds tracked by Wall St. Rank hold TECX as of Q1 2020.

  • Bessemer Group reported no remaining Tectonic Therapeutic position as of Q1 2020 after selling out during the quarter.
  • Bessemer Group sold 1,048 Tectonic Therapeutic shares in Q1 2020, an estimated $253K.
  • Bessemer Group first reported a position in Tectonic Therapeutic in Q2 2019 and held it in 3 quarters.
  • Bessemer Group's Tectonic Therapeutic position peaked at $336K in Q2 2019.
  • 92 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2020.

Based on Bessemer Group's 13F filing for Q1 2020, filed 30 Apr 2020.